Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, New Jersey. ORCID: https://orcid.org/0000-0001-7169-8520.
Pharmacy Practice and Administration, Director of Assessment, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, New Jersey; Clinical Pharmacist, Barnabas Health Retail Pharmacy, RWJBarnabas Health, Livingston, New Jersey.
J Opioid Manag. 2022 Mar-Apr;18(2):161-166. doi: 10.5055/jom.2022.0706.
To benchmark opioid abuse risk among student pharmacists attending three northeast pharmacy schools utilizing the opioid risk tool (ORT).
A cross-sectional, anonymous risk assessment questionnaire.
Three pharmacy schools in the northeast United States.
Professional year 1 (P1) through professional year 3 (P3) student pharmacists.
ORT was collected and scored by investigators and inputted into an electronic format for analysis. Students voluntarily participated, and 812 surveys were completed during one course meeting time and day at each school.
The majority of students were in the low-risk category (n = 581, 71.6 percent). Additionally, 137 (16.9 percent) patients were categorized as moderate risk and 94 (11.6 percent) as high risk. No statistically significant differences existed when comparing risk groups across the first through third professional year student pharmacist cohorts. There were no statistically significant differences in the proportion of risk groups among the three pharmacy cohorts between low-risk versus the high-risk groups. When comparing risk groups by gender, males were found to have a statistically significant higher proportion of being classified as moderate or high risk.
The results of this study demonstrate that there may be some student pharmacists with an increased risk for opioid abuse potential. There is potential need for education regarding opioid risk awareness and abuse prevention, which may serve as a call to action for professional school students and practitioners to understand baseline opioid abuse risk if they require chronic pain therapy.
利用阿片类药物风险工具（ORT）对参加三所东北药学学校的学生药剂师的阿片类药物滥用风险进行基准测试。
横断面、匿名风险评估问卷。
美国东北部的三所药学学校。
专业一年级（P1）至专业三年级（P3）的学生药剂师。
ORT 由调查人员收集和评分，并输入电子格式进行分析。学生自愿参与，每所学校在一次课程会议期间和一天内完成了 812 份调查。
大多数学生处于低风险类别（n=581，71.6%）。此外，137 名（16.9%）患者被归类为中度风险，94 名（11.6%）为高风险。在比较第一至第三年专业学生药剂师队列的风险组时，没有统计学上的显著差异。在三个药学队列中，低风险组与高风险组之间，风险组的比例没有统计学上的显著差异。当按性别比较风险组时，发现男性被归类为中度或高度风险的比例具有统计学意义上的显著差异。
这项研究的结果表明，可能有一些学生药剂师存在阿片类药物滥用的风险增加。可能需要进行有关阿片类药物风险意识和滥用预防的教育，这可能会促使专业学校的学生和从业者采取行动，了解他们如果需要慢性疼痛治疗，那么他们的基线阿片类药物滥用风险。
